The 2026 Concert for Cures at San Diego’s Petco Park became a major philanthropic moment when global artist P!NK led a crowd of roughly 25,000 and the evening generated $8.25 million for Curebound. The show combined high-energy performance with fundraising goals, and included special recognition for cancer survivors who made up a notable portion of the audience.
Organizers stressed that the night was more than entertainment: it was a targeted effort to accelerate research into adult and pediatric cancers. The results of the benefit add to multi-year progress and highlight how large-scale events can serve as catalysts for scientific investment.
Concert highlights and attendance
P!NK’s set at Petco Park featured her trademark mix of dynamic production and moments of intimacy, drawing sustained applause and emotional responses from the crowd. The stadium was filled not only with longtime fans but also with survivors—approximately 1,500 were invited by the Manchester Family Foundation to attend. The concert atmosphere balanced celebration with purpose as attendees and artists focused on funding research.
Artist profile and recognition
P!NK, who debuted in 2000 and has released nine studio albums plus a greatest hits collection, has sold more than 60 million albums globally. Her catalog includes 15 Top 10 hits on the Billboard Hot 100 with four reaching No. 1. Industry accolades include three Grammy Awards from 21 nominations, and she was named a nominee for the 2026 Rock & Roll Hall of Fame. On stage she voiced support for Curebound’s mission, calling attention to the urgency of cancer research.
Fundraising impact and Curebound’s work
The Concert for Cures event produced $8.25 million in new funding, bringing the four-year concert series total to more than $28 million directed to research. Since launching in 2026, the concerts have drawn over 60,000 attendees and evolved into Curebound’s flagship fundraiser, channeling major gifts toward strategic scientific programs.
Research investment and measurable outcomes
Curebound has distributed $51.5 million in cancer research grants, supporting some 170 studies that span 23 types of adult and pediatric cancer. Those awards have catalyzed follow-on progress: 30 expanded clinical trials reached a total of 1,864 patients and unlocked about $161 million in subsequent funding. Leaders emphasize that these metrics translate into clinical choices and additional time for families facing cancer.
Community, leadership and partnerships
Curebound’s CEO, Robin Toft, used the platform to underscore the broader stakes: in a funding environment where national support can be unpredictable, community-driven resources are increasingly important to sustain innovative science. Board Chair Rick Valencia, who co-chaired the concert committee with his daughter Aubrey Salvati, framed success in human terms: research breakthroughs expand treatment options and create more shared time for families.
Sponsors also contributed to the evening’s capacity to raise funds, with luxury brand Chopard among the partners supporting the event. Curebound’s event history includes high-profile headliners such as Elton John at Petco Park, Alicia Keys with the San Diego Symphony, and Ed Sheeran at the Rady Shell at Jacobs Park, illustrating how the concert series connects popular artists with scientific causes.
Why events matter for research
Large benefit concerts do more than generate immediate dollars: they raise awareness, consolidate donor networks, and provide flexible capital that scientific teams can deploy quickly. Curebound’s model emphasizes strategic grants that seed studies and help projects reach clinical trial phases, a process that often requires nimble funding to move from discovery to patient impact.
By combining a marquee performer like P!NK with survivor visibility and institutional partnerships, the Concert for Cures functions as both a public celebration and a funding mechanism. The $8.25 million raised at Petco Park is intended to underwrite research priorities that may define how cancer is prevented, detected, and treated for years to come.